McGill University Health Centre- Montreal General Hospital

Montreal, Quebec H3G 1A4

0 studies enrolling now · 9 studies all time

What they study most

ASCVD, Colitis, Ulcerative, Coronary Heart Disease (CHD), Crohn's Disease, Gastric Cancer, Gastroesophageal Junction Cancer, Gastrointestinal Hemorrhage (Clinically Important, Upper), Progressive Supranuclear Palsy, Ulcerative Colitis

Studies at this site

• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial — Completed
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy — Completed